Spending the same to end up getting less.
In all the hoopla about consumer spending – which accounts for about two-thirds of the US economy – and how lethargic its growth has been, despite some months when it perked up and gave rise to hopes that “escape velocity” would finally kick in, something got lost: how totally range-bound, for the past four years, discretionary spending has been.
This measure of discretionary spending excludes household bills and major items, such as cars or homes. It hasn’t budged in dollar terms for four years, despite inflation eating into the purchasing power of the dollar.
In August, spending by American households dropped once again, according to the Gallup US Daily survey released today. As part of this broad survey, based on telephone interviews (60% cell phone, 40% landline) conducted in August of over 15,000 adults, Gallup asks how much they spent “yesterday” on items excluding normal household bills and major purchases, such as a home or car. Gallup calls it an “indication of discretionary spending.”
united states stock market: Black Box Corporation(BBOX)
Advisors’ Opinion:
- [By Monica Gerson]
Black Box Corporation (NASDAQ: BBOX) is expected to post its quarterly earnings at $0.26 per share on revenue of $218.41 million.
Posted-In: Earnings scheduleEarnings News Pre-Market Outlook Markets
united states stock market: Datawatch Corporation(DWCH)
Advisors’ Opinion:
- [By Lisa Levin]
Datawatch Corporation (NASDAQ: DWCH) shares were also up, gaining 14 percent to $8.10 after the company reported a narrower-than-expected quarterly loss.
united states stock market: Ionis Pharmaceuticals, Inc.(IONS)
Advisors’ Opinion:
- [By Keith Speights]
Research and development is the lifeblood of biotech companies. The potential for new drugs also serves as a primary factor driving biotech stocks higher and higher. That’s been the case for Celgene (NASDAQ:CELG), Ionis Pharmaceuticals (NASDAQ:IONS), and Ligand Pharmaceuticals (NASDAQ:LGND).
- [By WWW.THESTREET.COM]
Coming up in this episode of Mad Money: Cramer interviews Dr. Stanley Crooke, CEO of Ionis Pharmaceuticals (IONS) . And, here’s Cramer’s read on Trump’s view of China. Plus, don’t miss the Lightning Round. Which stocks in Cramer bullish on?
- [By Elizabeth Balboa]
Here is a preview of the offerings set between June 27 and June 30.
11 IPOs This Week Avenue Therapeutics, Inc. (ATXI) will issue 5 million shares between $5 and $7 Tuesday on the Nasdaq. A Fortress Biotech Inc (NASDAQ: FBIO) subsidiary, the pharmaceutical acquires, develops and commercializes products for in-hospital use, such as its post-operative palliative. Esquire Financial Holdings, Inc. (ESQ) will issue more than 2.36 shares between $14 and $16 Tuesday on the Nasdaq. The business-focused commercial bank has two locations in New York and Florida. Mersana Therapeutics, Inc. (MRSN) will issue 5 million shares between $14 and $16 Wednesday on the Nasdaq. The clinical-stage pharmaceutical specializes in immunoconjugate therapies targeting diverse forms of cancer. TPG Pace Holdings Corp. (TPGHU) will issue 40 million shares at $10 Wednesday on the New York Stock Exchange. Formed by TPG, the firm acquires relevant businesses and stocks across industries, from health care and digital media to real estate and energy. Aileron Therapeutics Inc (ALRN) will issue 3.75 million shares between $15 and $17 Thursday on the Nasdaq. The biopharmaceutical firm targets suppressor proteins to halt tumor progression. Blue Apron Holdings, Inc. (APRN) will issue 30 million shares between $15 and $17 Thursday on the NYSE. The meal-kit service delivers pre-portioned ingredients directly to the consumer. Byline Bancorp, Inc. (BY) will issue 5.7 million shares between $19 and $21 Thursday on the NYSE. The century-old commercial bank has more than 50 branches in the Chicago and Milwaukee areas with offices nationwide. Dova Pharmaceuticals, Inc.(DOVA) will issue more than 4.06 million shares between $15 and $17 Thursday on the Nasdaq. As a clinical-stage company, Dova acquires, develops and commercializes drug candidates for rare diseases. Tintri, Inc. (TNTR) will issue 8.7 million shares between $10.50 and $12.50 Thursday on the Nasdaq. With cloud management software, all-flash stor
- [By Brian Orelli]
Ionis Pharmaceuticals (NASDAQ:IONS) gave investors an update on its pipeline today with a slide deck that contained a whopping 65 entries. The whole presentation is worth a listen, but here are the five slides investors absolutely must see.
- [By Cory Renauer]
Treating diseases that have a genetic component by altering the expression of the responsible genes is a promising new field of medicine, but it has been much less straightforward than biopharmaceutical companies had expected. Two contenders in this area, Alnylam Pharmaceuticals (NASDAQ:ALNY) and Ionis Pharmaceuticals (NASDAQ:IONS), saw a mix of setbacks and success in 2016.
united states stock market: Gentex Corporation(GNTX)
Advisors’ Opinion:
- [By Lisa Levin] Related TRST Earnings Scheduled For October 21, 2016 Major Accounting Changes Are Coming To The Financial Industry
Related MORN One Of The World's Most Powerful Women, Fidelity Personal Investing President Kathleen Murphy, To Tell Her Story At The Benzinga Global Fintech Awards The 2017 Benzinga Global Fintech Awards Will Include An 'Unprecedented Group' Of Judges Morningstar Packs Conference Lineup For Financial Advisors (Investor’s Business Daily) Companies Reporting Before The Bell
Rockwell Collins, Inc. (NYSE: COL) is estimated to report quarterly earnings at $1.31 per share on revenue of $1.33 billion.
General Electric Company (NYSE: GE) is expected to report quarterly earnings at $0.17 per share on revenue of $26.46 billion.
Honeywell International Inc. (NYSE: HON) is estimated to report quarterly earnings at $1.60 per share on revenue of $9.32 billion.
Interpublic Group of Companies Inc (NYSE: IPG) is expected to report quarterly earnings at $0.03 per share on revenue of $1.76 billion.
Schlumberger Limited. (NYSE: SLB) is estimated to report quarterly earnings at $0.26 per share on revenue of $7.02 billion.
SunTrust Banks, Inc. (NYSE: STI) is expected to report quarterly earnings at $0.83 per share on revenue of $2.21 billion.
ManpowerGroup Inc. (NYSE: MAN) is projected to report quarterly earnings at $1.11 per share on revenue of $4.68 billion.
Kansas City Southern (NYSE: KSU) is estimated to report quarterly earnings at $1.15 per share on revenue of $593.82 million.
Stanley Black & Decker, Inc. (NYSE: SWK) is projected to report quarterly earnings at $1.19 per share on revenue of $2.74 billion.
WABCO Holdings Inc. (NYSE: WBC) is estimated to report quarterly earnings at $1.44 per share on revenue of $721.89 million.
united states stock market: Revlon, Inc.(REV)
Advisors’ Opinion:
- [By Lee Jackson]
These companies also reported insider buying last week: Apache Corp. (NYSE: APA), Halliburton Co. (NYSE: HAL), Revlon Inc. (NYSE: REV), Valeant Pharmaceuticals International Inc. (NYSE: VRX) and U.S. Steel Corp. (NYSE: X).
- [By Jeremy Bowman]
Shares of Revlon, Inc.(NYSE:REV) surged last month after the company announced a restructuring plan. According to data from S&P Global Market Intelligence, the stock gained 15%. The bulk of the increase came in the middle of the month when the restructuring plan was announced.
